The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
General Drugs Wholesale Purchasing World Report
US$ 950.00
GENERAL DRUGS WHOLESALE PURCHASING WORLD PDF REPORT See descriptive brochure: here The General Drugs Wholesale Purchasing World Report gives data on a list of 42 categories of Raw Materials, Semi-Finished & ... , by each country, by Year. This General Drugs Wholesale Purchasing World Report is a PDF Summary Edition.802 pages. Updated monthly. UPGRADE: A Purchasing World Database Edition of this report is available ...
September 2019
802 pages
General-Line Drugs Wholesale Revenues Global Report
US$ 950.00
... Coupon value of $300. GENERAL-LINE DRUGS WHOLESALE REVENUES WORLD REPORT DATABASE EDITION The Market for General-Line Drugs Wholesale Revenues in each country by Products & Services. The General-Line Drugs Wholesale Revenues World Report covers ...
September 2019
859 pages
Specialty-Line Drugs Wholesale Revenues Global Report
US$ 950.00
... Coupon value of $300. SPECIALTY-LINE DRUGS WHOLESALE REVENUES WORLD REPORT DATABASE EDITION The Market for Specialty-Line Drugs Wholesale Revenues in each country by Products & Services. The Specialty-Line Drugs Wholesale Revenues World Report covers ...
September 2019
882 pages
Investigation Report on China's Finasteride Market, 2019-2023
US$ 2,200.00
... prostatic hyperplasia in China Status of China's Finasteride market Competition on China's Finasteride market Major Finasteride manufacturers in China Prices of Finasteride in China Major factors influencing the development of China's Finasteride market Prospect of China's Finasteride market from ...
September 2019
30 pages
Investigation Report on China's Pegaspargase Market, 2019-2023
US$ 2,200.00
... of leukemia in China Status of China's Pegaspargase market Retail prices of Pegaspargase in China Major factors influencing the development of China's Pegaspargase market Prospect of China's Pegaspargase market from 2019 to 2023 Progress of generic Pegaspargase in China
September 2019
30 pages
Investigation Report on China's Prothrombin Complex Concentrate (PCC) Market, 2019-2023
US$ 2,200.00
... hemophiliacs in China at the end of 2018. And most of them failed to receive timely treatment because they had no ability to pay. Prothrombin complex concentrate (PCC ... of PCC and there are few manufacturers of PCC in China, China’s PCC market is highly concentrated with CR5 of more than 90%. In 2017, Hualan ...
September 2019
30 pages
Carcinoid Syndrome- Pipeline Insight, 2019
US$ 1,250.00
... Carcinoid Syndrome- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Carcinoid Syndrome pipeline ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages
Chagas Disease - Pipeline Insight, 2019
US$ 1,250.00
... Chagas Disease pipeline landscape is provided which includes the disease overview and Chagas Disease treatment guidelines. The assessment part of the report embraces, in depth Chagas Disease commercial assessment and clinical ...
August 2019
60 pages
Chronic Neuropathic Pain (CNP) - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Chronic Neuropathic Pain treatment guidelines. The assessment part of the report embraces, in depth Chronic Neuropathic Pain commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Gorlin Syndrome - Pipeline Insight, 2019
US$ 1,250.00
... Gorlin Syndrome treatment guidelines. The assessment part of the report embraces, in depth Gorlin Syndrome commercial assessment and clinical assessment of the pipeline ... traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor ...
August 2019
60 pages
Graves’ Ophthalmopathy - Pipeline Insight, 2019
US$ 1,250.00
... Graves’ Ophthalmopathy Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...
August 2019
60 pages
Hypoactive Sexual Desire Disorder (HSDD) - Pipeline Insight, 2019
US$ 1,250.00
... therapy (which has been the standard treatment for HSDD for a long time), Testosterone treatment (Menopausal women with HSDD). Hypoactive Sexual Desire Disorder (HSDD) Pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...
August 2019
60 pages
Hypothalamic Obesity (HO) - Pipeline Insight, 2019
US$ 1,250.00
... Hypothalamic Obesity treatment guidelines. The assessment part of the report embraces, in depth Hypothalamic Obesity commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...
August 2019
60 pages
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Idiopathic CD4+ Lymphocytopenia treatment guidelines. The assessment part of the report embraces, in depth Idiopathic CD4+ Lymphocytopenia commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Lactose Intolerance - Pipeline Insight, 2019
US$ 1,250.00
... Lactose malassimilation. Lactose Intolerance Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages
Lambert-Eaton Myasthenic Syndrome (LEMS)- Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Lambert-Eaton Myasthenic Syndrome (LEMS) treatment guidelines. The assessment part of the report embraces, in depth Lambert-Eaton Myasthenic Syndrome (LEMS) commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Phosphoglucomutase (PGM 1) Deficiency- Pipeline Insight, 2019
US$ 1,250.00
... report which includes Company-Company Collaborations (Licensing / Partnering), Company-Academia Collaborations, and Acquisition analysis in both Graphical and tabulated form. Phosphoglucomutase (PGM 1) Deficiency Clinical Assessment of products ...
August 2019
60 pages
Post-Transplant Lymphoproliferative Disorder- Pipeline Insight, 2019
US$ 1,250.00
... post-transplant lymphoproliferative disease. Early diagnosis and prompt treatment of these disorders are extremely important. Post-Transplant Lymphoproliferative Disorder Pipeline Development Activities The report provides insights ... databases, company/university websites, clinical trial registries, conferences ...
August 2019
60 pages
Primary Biliary Cholangitis - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Primary Biliary Cholangitis treatment guidelines. The assessment part of the report embraces, in depth Primary Biliary Cholangitis commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Primary Progressive Aphasia - Pipeline Insight, 2019
US$ 1,250.00
... disease overview and Primary Progressive Aphasia treatment guidelines. The assessment part of the report embraces, in depth Primary Progressive Aphasia commercial assessment and clinical assessment of the pipeline products under ...
August 2019
60 pages
Proteus Syndrome - Pipeline Insight, 2019
US$ 1,250.00
... Proteus syndrome. Proteus Syndrome Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... 's proprietary databases, company/university websites, clinical trial registries, conferences, SEC ...
August 2019
60 pages
Pruritis - Pipeline Insight, 2019
US$ 1,250.00
... 24 Hours "Pruritis - Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present ... Drugs under development as a monotherapy or combination therapy are also included. It also analyses key players involved in Pruritis ... databases, company/university websites, clinical trial registries, ...
August 2019
60 pages
Pseudoxanthoma Elasticum- Pipeline Insight, 2019
US$ 1,250.00
... Pseudoxanthoma Elasticum- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Pseudoxanthoma Elasticum pipeline ... databases, company/university websites, clinical trial registries, conferences ...
August 2019
60 pages
Pyoderma Gangrenosum (PG) - Pipeline Insight, 2019
US$ 1,250.00
... Pyoderma Gangrenosum treatment guidelines. The assessment part of the report embraces, in depth Pyoderma Gangrenosum commercial assessment and clinical assessment of the pipeline ... from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, ...
August 2019
60 pages
Recessive Dystrophic Epidermolysis (RDEB)- Pipeline Insight, 2019
US$ 1,250.00
... RDEB-SG. Recessive Dystrophic Epidermolysis Pipeline Development Activities The report provides insights into different therapeutic candidates in discovery and preclinical, phase 1, phase 2, and phase 3 stage. Drugs ... 's proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages
Refractory Epilepsy- Pipeline Insight, 2019
US$ 1,250.00
... Refractory Epilepsy- Pipeline Insight, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Refractory Epilepsy pipeline ... proprietary databases, company/university websites, clinical trial registries, conferences, ...
August 2019
60 pages